Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Aumolertinib challenge as an optional treatment in advanced non small‑cell lung cancer after osimertinib failure with epidermal growth factor receptor‑sensitive mutation: A case series
PaperCitations, authors & open-access status
Aumolertinib challenge as an optional treatment in advanced non small‑cell lung cancer after osimertinib failure with epidermal growth factor receptor‑sensitive mutation: A case series is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 5 citations, 2022 year and diamond oa status.
5
Citations
2022
Year
diamond
OA Status